UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2016-12, Vol.30 (6), p.525-570

2016

Volltextzugriff (PDF)

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

Arthritis research & therapy, 2018-07, Vol.20 (1), p.155-155, Article 155

2018

Volltextzugriff (PDF)

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

Arthritis research & therapy, 2018-08, Vol.20 (1), p.178-178, Article 178

2018

Volltextzugriff (PDF)

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

Patient preference and adherence, 2016-01, Vol.10 (Issue 1), p.937-948

2016

Volltextzugriff (PDF)

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

Clinical journal of the American Society of Nephrology, 2010-08, Vol.5 (8), p.1420-1428

2010

Volltextzugriff (PDF)

Biosimilars Have Arrived: Rituximab

Arthritis, 2018-01, Vol.2018, p.3762864-6

2018

Volltextzugriff (PDF)

A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing

British journal of clinical pharmacology, 2020-11, Vol.86 (11), p.2182-2191

2020

Volltextzugriff (PDF)

Biosimilar biologic drugs: a new frontier in medical care

Postgraduate medicine, 2017-05, Vol.129 (4), p.460-470

2017

Volltextzugriff (PDF)

Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha

The Journal of pharmacology and experimental therapeutics, 2002-12, Vol.303 (3), p.1334-1343

2002

Volltextzugriff (PDF)

Prediction of clinical responses in a simulated phase III trial of Crohn's patients administered the antisense phosphorothioate oligonucleotide ISIS 2302: comparison of proposed dosing regimens

Antisense & nucleic acid drug development, 2003-02, Vol.13 (1), p.57-66

2003

Volltextzugriff (PDF)

Rheumatoid Arthritis in Older Adults

Clinics in geriatric medicine, 1998-08, Vol.14 (3), p.475-494

Sewell, K. Lea

1998

Volltextzugriff (PDF)

The Effect of Minocycline in Rat Models of Inflammatory Arthritis: Correlation of Arthritis Suppression with Enhanced T Cell Calcium Flux

Cellular immunology, 1996-02, Vol.167 (2), p.195-204

1996

Volltextzugriff (PDF)

SYSTEMIC LUPUS ERYTHEMATOSUS AS A CAUSE OF FAILURE TO THRIVE IN OLDER PEOPLE

Journal of the American Geriatrics Society (JAGS), 1996-03, Vol.44 (3), p.337-338

1996

Volltextzugriff (PDF)

Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus

The American journal of medicine, 1989-05, Vol.86 (1), p.625-626

1989

Volltextzugriff (PDF)

Suppression of collagen‐induced arthritis through adenovirus‐mediated transfer of a modified tumor necrosis factor α receptor gene

Arthritis and rheumatism, 1997-09, Vol.40 (9), p.1662-1669

1997

Volltextzugriff (PDF)

Iatrogenic osteoporosis

Archives of dermatology (1960), 1995-11, Vol.131 (11), p.1321

Sewell, K L

1995

Volltextzugriff (PDF)

Interleukin‐2 diphtheria fusion protein (dab486il‐2) in refractory rheumatoid arthritis a double‐blind, placebo‐controlled trial with open‐label extension

Arthritis and rheumatism, 1995-09, Vol.38 (9), p.1177-1186

1995

Volltextzugriff (PDF)

Health status response of rheumatoid arthritis to treatment with DAB486IL‐2

Arthritis and rheumatism, 1996-04, Vol.9 (2), p.112-119

1996

Volltextzugriff (PDF)

CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor

Proceedings of the National Academy of Sciences - PNAS, 2021-07, Vol.118 (29), p.1

2021

Volltextzugriff (PDF)

Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis

Science (American Association for the Advancement of Science), 1993-09, Vol.261 (5129), p.1727-1730

1993

Volltextzugriff (PDF)

Pathogenesis of rheumatoid arthritis

The Lancet (British edition), 1993-01, Vol.341 (8840), p.283-286

1993

Volltextzugriff (PDF)

Immunotherapy and other novel therapies, including biologic response modifiers, apheresis, and dietary modifications

Current opinion in rheumatology, 1993-05, Vol.5 (3), p.293-298

Sewell, Kathryn Lea

1993

Volltextzugriff (PDF)

Treatment of Elderly-Onset Rheumatoid Arthritis

Journal of the American Geriatrics Society (JAGS), 1991-10, Vol.39 (10), p.1043-1044

Sewell, Kathryn Lea

1991

Volltextzugriff (PDF)

Misdiagnosis of Rheumatoid Arthritis in an Elderly Woman with Gout

Journal of the American Geriatrics Society (JAGS), 1991-04, Vol.39 (4), p.403-406

1991

Volltextzugriff (PDF)

Modern Therapeutic Approaches to Osteoporosis

Rheumatic diseases clinics of North America, 1989-08, Vol.15 (3), p.583-614

Sewell, Kathryn Lea

1989

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Humans
(20)
Life Sciences & Biomedicine
(20)
Female
(8)
Aged
(7)
Arthritis
(7)
Male
(7)
Adult
(6)
Biological And Medical Sciences
(6)
Rheumatoid Arthritis
(6)
Medical Sciences
(5)
Rheumatology
(5)
Animals
(4)
Arthritis, Rheumatoid - Drug Therapy
(4)
Biological Products
(4)
Biosimilar
(4)
General & Internal Medicine
(4)
Geriatrics & Gerontology
(4)
Immunotherapy
(4)
Medicine, General & Internal
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

Patient attitudes and understanding about biosimilars: an international cross-sectional survey

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

Biosimilars Have Arrived: Rituximab

A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing

Biosimilar biologic drugs: a new frontier in medical care

Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha

Prediction of clinical responses in a simulated phase III trial of Crohn's patients administered the antisense phosphorothioate oligonucleotide ISIS 2302: comparison of proposed dosing regimens

Rheumatoid Arthritis in Older Adults

The Effect of Minocycline in Rat Models of Inflammatory Arthritis: Correlation of Arthritis Suppression with Enhanced T Cell Calcium Flux

SYSTEMIC LUPUS ERYTHEMATOSUS AS A CAUSE OF FAILURE TO THRIVE IN OLDER PEOPLE

Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus

Suppression of collagen‐induced arthritis through adenovirus‐mediated transfer of a modified tumor necrosis factor α receptor gene

Iatrogenic osteoporosis

Interleukin‐2 diphtheria fusion protein (dab486il‐2) in refractory rheumatoid arthritis a double‐blind, placebo‐controlled trial with open‐label extension

Health status response of rheumatoid arthritis to treatment with DAB486IL‐2

CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor

Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis

Pathogenesis of rheumatoid arthritis

Immunotherapy and other novel therapies, including biologic response modifiers, apheresis, and dietary modifications

Treatment of Elderly-Onset Rheumatoid Arthritis

Misdiagnosis of Rheumatoid Arthritis in an Elderly Woman with Gout

Modern Therapeutic Approaches to Osteoporosis

Suchergebnisse filtern